These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21254170)

  • 1. Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy.
    Lewindon PJ; Shepherd RW; Walsh MJ; Greer RM; Williamson R; Pereira TN; Frawley K; Bell SC; Smith JL; Ramm GA
    Hepatology; 2011 Jan; 53(1):193-201. PubMed ID: 21254170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
    Leung DH; Khan M; Minard CG; Guffey D; Ramm LE; Clouston AD; Miller G; Lewindon PJ; Shepherd RW; Ramm GA
    Hepatology; 2015 Nov; 62(5):1576-83. PubMed ID: 26223427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance for cystic fibrosis-associated hepatobiliary disease: early ultrasound changes and predisposing factors.
    Lenaerts C; Lapierre C; Patriquin H; Bureau N; Lepage G; Harel F; Marcotte J; Roy CC
    J Pediatr; 2003 Sep; 143(3):343-50. PubMed ID: 14517517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis.
    Calvopina DA; Lewindon PJ; Ramm LE; Noble C; Hartel GF; Leung DH; Ramm GA
    J Cyst Fibros; 2022 Mar; 21(2):236-242. PubMed ID: 34953741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease.
    Kitson MT; Kemp WW; Iser DM; Paul E; Wilson JW; Roberts SK
    Liver Int; 2013 May; 33(5):698-705. PubMed ID: 23432782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ultrasound and biopsy findings in children with cystic fibrosis related liver disease.
    Mueller-Abt PR; Frawley KJ; Greer RM; Lewindon PJ
    J Cyst Fibros; 2008 May; 7(3):215-21. PubMed ID: 17904429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs as noninvasive diagnostic biomarkers of liver disease in children with cystic fibrosis.
    Cook NL; Pereira TN; Lewindon PJ; Shepherd RW; Ramm GA
    J Pediatr Gastroenterol Nutr; 2015 Feb; 60(2):247-54. PubMed ID: 25625579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multidisciplinary Approach to Pretransplant and Posttransplant Management of Cystic Fibrosis-Associated Liver Disease.
    Freeman AJ; Sellers ZM; Mazariegos G; Kelly A; Saiman L; Mallory G; Ling SC; Narkewicz MR; Leung DH
    Liver Transpl; 2019 Apr; 25(4):640-657. PubMed ID: 30697907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.
    Pereira TN; Lewindon PJ; Smith JL; Murphy TL; Lincoln DJ; Shepherd RW; Ramm GA
    J Hepatol; 2004 Oct; 41(4):576-83. PubMed ID: 15464237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A scoring system for predicting significant fibrosis in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase levels.
    Wang H; Yan R; Zhou Y; Wang MS; Ruo GQ; Cheng MJ
    J Clin Gastroenterol; 2015 Jan; 49(1):69-75. PubMed ID: 24518795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up and liver outcomes in children with cystic fibrosis and nodular liver on ultrasound in a multi-center study.
    Leung DH; Ye W; Schwarzenberg SJ; Freeman AJ; Palermo JJ; Weymann A; Alonso EM; Karnsakul WW; Murray KF; Stoll JM; Huang S; Karmazyn B; Masand P; Magee JC; Alazraki AL; Towbin AJ; Nicholas JL; Green N; Otto RK; Siegel MJ; Ling SC; Navarro OM; Harned RK; Narkewicz MR; Molleston JP;
    J Cyst Fibros; 2023 Mar; 22(2):248-255. PubMed ID: 35985930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis.
    Calvopina DA; Chatfield MD; Weis A; Coleman MA; Fernandez-Rojo MA; Noble C; Ramm LE; Leung DH; Lewindon PJ; Ramm GA
    Hepatology; 2018 Dec; 68(6):2301-2316. PubMed ID: 30014495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study on the use of acoustic radiation force impulse imaging in the staging of cystic fibrosis associated liver disease.
    Manco M; Zupone CL; Alghisi F; D'Andrea ML; Lucidi V; Monti L
    J Cyst Fibros; 2012 Sep; 11(5):427-32. PubMed ID: 22538068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of cystic fibrosis liver disease a prospective cohort study.
    Rowland M; Drummond J; Connolly L; Daly E; McCormick PA; Bourke B; ;
    J Cyst Fibros; 2023 Nov; 22(6):1054-1061. PubMed ID: 37495468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
    Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR
    PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial splenectomy for portal hypertension in cystic fibrosis related liver disease.
    Louis D; Duc ML; Reix P; Chazalette JP; Durieu I; Feigelson J; Bellon G
    Pediatr Pulmonol; 2007 Dec; 42(12):1173-80. PubMed ID: 17968998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum alpha-glutathione S-transferase as a sensitive marker of hepatocellular damage in patients with cystic fibrosis.
    Sídlová K; Skalická V; Kotaska K; Pechová M; Chada M; Bartosová J; Hríbal Z; Nevoral J; Vávrová V; Průsa R
    Physiol Res; 2003; 52(3):361-5. PubMed ID: 12790769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
    Stránský J; Ryzlová M; Striteský J; Horák J
    Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of acoustic radiation force impulse/serum noninvasive markers for fibrosis prediction in liver transplant.
    Pinto J; Matos H; Nobre S; Cipriano MA; Marques M; Pereira JM; Gonçalves I; Noruegas MJ
    J Pediatr Gastroenterol Nutr; 2014 Mar; 58(3):382-6. PubMed ID: 24164902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis.
    Nash EF; Volling C; Gutierrez CA; Tullis E; Coonar A; McRae K; Keshavjee S; Singer LG; Durie PR; Chaparro C
    Clin Transplant; 2012; 26(1):34-41. PubMed ID: 21272072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.